JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

A2586 Nafamostat Mesylate(FUT-175)

Summary: Serine protease inhibitor

≥27 mg/mL
A4127 GSK1070916

Target: Aurora Kinases

Summary: Aurora B/C inhibitor

≥25.4 mg/mL
A4128 PF-03814735

Target: Aurora Kinases

Summary: Aurora A/B inhibitor

Soluble in DMSO
A2588 PPACK Dihydrochloride

Summary: Thrombin inhibitor

≥49.5 mg/mL
A2610 Fenbendazole

Summary: For pinworm treatment in animals

insoluble in EtOH; insoluble in H2O; ≥7.48 mg/mL
A4208 NSC 319726

Target: p53

Summary: Reactivator of mutant p53
A4209 NSC 207895 (XI-006)

Target: MDMX

Summary: MDMX inhibitor,anti-cancer agent
A4210 Bay 11-7821 (BAY 11-7082)
1 Citation

Summary: IKK/NF-κB/TNFα inhibitor

insoluble in H2O; ≥64 mg/mL
A4211 Lenalidomide (CC-5013)

Target: angiogenesis

Summary: Antineoplastic agent,inhibits angiogenesis

insoluble in EtOH; insoluble in H2O; ≥100.8 mg/mL
A4212 Pomalidomide (CC-4047)

Summary: Immunomodulator,antumor/anti-angiogenic

insoluble in EtOH; insoluble in H2O; ≥7.5 mg/mL